Dörken B - Search Results

1

Cellular senescence in cancer treatment: friend or foe?

Kahlem P, Dörken B, Schmitt CA. Kahlem P, et al. Among authors: dorken b. J Clin Invest. 2004 Jan;113(2):169-74. doi: 10.1172/JCI20784. J Clin Invest. 2004. PMID: 14722606 Free PMC article. Review.

2

Extracorporeal photopheresis in graft-versus-host disease: ultraviolet radiation mediates T cell senescence in vivo.

Lee S, Dörken B, Schmitt CA. Lee S, et al. Among authors: dorken b. Transplantation. 2004 Aug 15;78(3):484-5. doi: 10.1097/01.tp.0000128835.06220.44. Transplantation. 2004. PMID: 15316381 No abstract available.

3

5-Aza-2'-deoxycytidine induces p21WAF expression by demethylation of p73 leading to p53-independent apoptosis in myeloid leukemia.

Schmelz K, Wagner M, Dörken B, Tamm I. Schmelz K, et al. Among authors: dorken b. Int J Cancer. 2005 May 1;114(5):683-95. doi: 10.1002/ijc.20797. Int J Cancer. 2005. PMID: 15609309

4

Recurrent chromosomal aberrations in INK4a/ARF defective primary lymphomas predict drug responses in vivo.

Helmrich A, Lee S, O'Brien P, Dörken B, Lowe SW, Schröck E, Schmitt CA. Helmrich A, et al. Among authors: dorken b. Oncogene. 2005 Jun 16;24(26):4174-82. doi: 10.1038/sj.onc.1208600. Oncogene. 2005. PMID: 15824738

5

Oncogene-induced senescence as an initial barrier in lymphoma development.

Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B, Stein H, Dörken B, Jenuwein T, Schmitt CA. Braig M, et al. Among authors: dorken b. Nature. 2005 Aug 4;436(7051):660-5. doi: 10.1038/nature03841. Nature. 2005. PMID: 16079837 Free article.

6

Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy.

Sturm I, Rau B, Schlag PM, Wust P, Hildebrandt B, Riess H, Hauptmann S, Dörken B, Daniel PT. Sturm I, et al. Among authors: dorken b. BMC Cancer. 2006 May 10;6:124. doi: 10.1186/1471-2407-6-124. BMC Cancer. 2006. PMID: 16686938 Free PMC article.

7

The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo.

Reimann M, Loddenkemper C, Rudolph C, Schildhauer I, Teichmann B, Stein H, Schlegelberger B, Dörken B, Schmitt CA. Reimann M, et al. Among authors: dorken b. Blood. 2007 Oct 15;110(8):2996-3004. doi: 10.1182/blood-2007-02-075614. Epub 2007 Jun 11. Blood. 2007. PMID: 17562874 Free article.

8

Tumor stroma-derived TGF-beta limits myc-driven lymphomagenesis via Suv39h1-dependent senescence.

Reimann M, Lee S, Loddenkemper C, Dörr JR, Tabor V, Aichele P, Stein H, Dörken B, Jenuwein T, Schmitt CA. Reimann M, et al. Among authors: dorken b. Cancer Cell. 2010 Mar 16;17(3):262-72. doi: 10.1016/j.ccr.2009.12.043. Cancer Cell. 2010. PMID: 20227040 Free article.

9

Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigations.

Jing H, Kase J, Dörr JR, Milanovic M, Lenze D, Grau M, Beuster G, Ji S, Reimann M, Lenz P, Hummel M, Dörken B, Lenz G, Scheidereit C, Schmitt CA, Lee S. Jing H, et al. Among authors: dorken b. Genes Dev. 2011 Oct 15;25(20):2137-46. doi: 10.1101/gad.17620611. Epub 2011 Oct 6. Genes Dev. 2011. PMID: 21979374 Free PMC article.

10

Synthetic lethal metabolic targeting of cellular senescence in cancer therapy.

Dörr JR, Yu Y, Milanovic M, Beuster G, Zasada C, Däbritz JH, Lisec J, Lenze D, Gerhardt A, Schleicher K, Kratzat S, Purfürst B, Walenta S, Mueller-Klieser W, Gräler M, Hummel M, Keller U, Buck AK, Dörken B, Willmitzer L, Reimann M, Kempa S, Lee S, Schmitt CA. Dörr JR, et al. Among authors: dorken b. Nature. 2013 Sep 19;501(7467):421-5. doi: 10.1038/nature12437. Epub 2013 Aug 14. Nature. 2013. PMID: 23945590

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

466 results

Search Page

Filters